HCWB HCW Biologics Inc Total Asset Value of Company
HCW Biologics Inc. (HCWB) is developing an innovative network to combat oncology and age-related pathologies through the TOBI system. The share price history demonstrates asset dynamics, which currently stand at 27.84. The company minimizes technological threats by creating immunity stimulation methods for the geriatric sector. Meanwhile, R&D funding is provided by grants, and strict FDA oversight monitors the safety of HCW9218 molecule therapy.
Analytical breakdowns and data insights for company hcwbiologics.com (HCWB)
- share price and consensus valuation forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio HCW Biologics Inc.|HCWB - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio HCW Biologics|HCWB - Company Aggregate Debts|Debts to Book Capitalization HCW Biologics|HCWB - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings HCW Biologics|Interim Coverage Ratio hcwbiologics.com
- net income and valuation multiples indicators:
Fundamental valuation:HCW Biologics Inc.
Total assets serve as an integral indicator of financial stability, which in this instance is reverse-calculated via return on assets (ROA) to assess the issuer's aggregate resources. An analysis of total capital and liabilities allows the investor to weigh the risk of asset impairment against bankruptcy protection, which for HCW Biologics Inc. (HCWB) is supported by the ownership of its own cGMP manufacturing facility in Florida, reducing operational dependence on third-party contractors.
Key competitors
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|Savara Corp - Company Total Assets|Aggregate Asset Value RIGL (Rigel Corp)|ANAB: Company Total Assets|Cumulative Company Assets astriatx.com|Cumulative Company Assets ENGN|Cumulative Company Assets RAPT Therapeutics Inc. (RAPT)|Cumulative Company Assets JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics, Inc) - Aggregate Asset Value|Company Total Assets KYTX (Kyverna Therapeutics)|tizianalifesciences.com - Aggregate Company Assets|Cabaletta Bio - Company Total Assets|Company Total Asset Base Ventyx Biosciences Inc. VTYX|Theratechnologies Inc (THTX) - Aggregate Company Assets|Company Assets Avalo Therapeutics Inc (AVTX)|Aggregate Company Assets Eledon Pharmaceuticals|Aggregate Company Assets AGEN|Aggregate Company Assets Climb Bio (CLYM)|ZURA - Company Assets|Company Total Assets ATYR (aTyr)|Company Balance Sheet Assets Adagene Inc|Ikena Oncology, Inc. - Company Total Assets|Company Total Asset Base Shattuck Labs, Inc. STTK|EQ: Company Total Assets|Cumulative Company Assets Connect Biopharma Holdings Limited|Aggregate Company Assets Immunic Therapeutics|Atara Biotherapeutics Inc (ATRA) - Company Total Asset Base|Cumulative Company Assets IFRX (InflaRx N.V.)|XFOR (x4pharma.com) - Aggregate Asset Value|Company Total Assets ACET (Adicet Bio, Inc.)|Company Total Asset Base Celularity Inc (CELU)|INMB - Aggregate Company Assets|BRNS (Barinthus Biotherapeutics Corp) - Total Business Assets|KZR: Company Total Assets|Cumulative Company Assets sabbiotherapeutics.com|Cumulative Company Assets AKTX|Enlivex Therapeutics, Ltd. (ENLV) - Company Total Asset Base|Company Total Assets QTTB|GOVX (GeoVax Corp) - Aggregate Asset Value|Company Total Assets EDSA (Edesa Biotech, Inc.)|IBIO - Cumulative Company Assets|CARM: Cumulative Company Assets|XTL Biopharmaceuticals Ltd (XTLB) - Cumulative Company Assets|BOLT: Company Total Assets|APVO (Aptevo Therapeutics Inc.) - Aggregate Company Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aditxt Corp - Total Asset Value of Company|Company Total Assets GRI|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Company Total Assets HIND (ReShape Lifesciences)|Company Total Assets Revelation Biosciences Corp REVB|INDP - Aggregate Company Assets|Aggregate Asset Value SCNI (scinai.com)|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|ALLK (Allakos Inc) - Company Total Assets|Company Total Assets HOOKIPA|Cumulative Company Assets IGMS (IGM Biosciences, Inc.)|ITOS (iteostherapeutics.com) - Aggregate Asset Value|Company Total Assets OCEA (Ocean Biomedical)|Company Total Asset Base TC BioPharm (Holdings) Plc (TCBP)|THRD - Aggregate Company Assets